Danaher Co. (NYSE: DHR) is now covered by analysts at Guggenheim. They set a "buy" rating and a $275.00 price target on the stock.
Australia Environmental Testing Market Report 2024-2031: Rising Adoption Among Government and R&D Laboratories Expected to Generate Growth Opportunities for Market Stakeholders [Yahoo! Finance]
James Webb Space Telescope best images of 2024 [USA TODAY]
Medical Devices Technologies and Global Market Outlook 2024-2029, with Profiles of Abbott, BD, Danaher, Medtronic and F. Hoffmann-La Roche [Yahoo! Finance]
Danaher Co. (NYSE: DHR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.